Advertisement

Pacing as a treatment for reflex-mediated (vasovagal, situational, or carotid sinus hypersensitivity) syncope: A systematic review for the 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope

A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

      Objectives

      To determine, using systematic review of the biomedical literature, whether pacing reduces risk of recurrent syncope and relevant clinical outcomes among adult patients with reflex-mediated syncope.

      Methods

      MEDLINE (through PubMed), EMBASE, and the Cochrane Central Register of Controlled Trials (through October 7, 2015) were searched for randomized trials and observational studies examining pacing and syncope, and the bibliographies of known systematic reviews were also examined. Studies were rejected for poor-quality study methods and for the lack of the population, intervention, comparator, or outcome(s) of interest.

      Results

      Of 3,188 citations reviewed, 10 studies met the inclusion criteria for systematic review, including a total of 676 patients. These included 9 randomized trials and 1 observational study. Of the 10 studies, 4 addressed patients with carotid sinus hypersensitivity, and the remaining 6 addressed vasovagal syncope. Among the 6 open-label (unblinded) studies, we found that pacing was associated with a 70% reduction in recurrent syncope (relative risk [RR]: 0.30; 95% confidence interval [CI]: 0.15–0.60). When the 2 analyzable studies with double-blinded methodology were considered separately, there was no clear benefit (RR: 0.73; 95% CI: 0.25–2.1), but confidence intervals were wide. The strongest evidence was from the randomized, double-blinded ISSUE-3 (Third International Study on Syncope of Uncertain Etiology) trial, which demonstrated a benefit of pacing among patients with recurrent syncope and asystole documented by implantable loop recorder.

      Conclusions

      There are limited data with substantive evidence of outcome ascertainment bias, and only 2 studies with a double-blinded study design have been conducted. The evidence does not support the use of pacing for reflex-mediated syncope beyond patients with recurrent vasovagal syncope and asystole documented by implantable loop recorder.

      KeyWords

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Sheldon R.S.
        • Grubb 2nd, B.P.
        • Olshansky B.
        • et al.
        2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope.
        Heart Rhythm. 2015; 12: e41-e63
        • Serletis A.
        • Rose S.
        • Sheldon A.G.
        • et al.
        Vasovagal syncope in medical students and their first-degree relatives.
        Eur Heart J. 2006; 27: 1965-1970
        • Ganzeboom K.S.
        • Mairuhu G.
        • Reitsma J.B.
        • et al.
        Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35-60 years.
        J Cardiovasc Electrophysiol. 2006; 17: 1172-1176
        • Sutton R.
        • Brignole M.
        • Menozzi C.
        • et al.
        Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope: pacemaker versus no therapy: a multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators.
        Circulation. 2000; 102: 294-299
        • Connolly S.J.
        • Sheldon R.
        • Roberts R.S.
        • et al.
        The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope.
        J Am Coll Cardiol. 1999; 33: 16-20
      1. Claesson JE, Kristensson BE, Edvardsson N, et al. Less syncope and milder symptoms in patients treated with pacing for induced cardioinhibitory carotid sinus syndrome: a randomized study. Europace. 2007;9:932–6.

        • Brignole M.
        • Menozzi C.
        • Moya A.
        • et al.
        Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial.
        Circulation. 2012; 125: 2566-2571
        • Brignole M.
        • Menozzi C.
        • Lolli G.
        • et al.
        Long-term outcome of paced and nonpaced patients with severe carotid sinus syndrome.
        Am J Cardiol. 1992; 69: 1039-1043
        • Russo V.
        • Rago A.
        • Papa A.A.
        • et al.
        The effect of dual-chamber closed-loop stimulation on syncope recurrence in healthy patients with tilt-induced vasovagal cardioinhibitory syncope: a prospective, randomised, single-blind, crossover study.
        Heart. 2013; 99: 1609-1613
        • Ryan D.J.
        • Nick S.
        • Colette S.M.
        • et al.
        Carotid sinus syndrome, should we pace? A multicentre, randomised control trial (Safepace 2).
        Heart. 2010; 96: 347-351
        • Raviele A.
        • Giada F.
        • Menozzi C.
        • et al.
        A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE).
        Eur Heart J. 2004; 25: 1741-1748
        • Lelonek M.
        • Goch J.H.
        Who das [sic] really benefit by the permanent cardiac pacing in cardiodepressive vasovagal syncope?.
        Clin Exp Med Lett. 2007; 48: 29-31
        • Kenny R.A.
        • Richardson D.A.
        • Steen N.
        • et al.
        Carotid sinus syndrome: a modifiable risk factor for nonaccidental falls in older adults (SAFE PACE).
        J Am Coll Cardiol. 2001; 38: 1491-1496
        • Flammang D.
        • Antiel M.
        • Church T.
        • et al.
        Is a pacemaker indicated for vasovagal patients with severe cardioinhibitory reflex as identified by the ATP test? A preliminary randomized trial.
        Europace. 1999; 1: 140-145
        • Connolly S.J.
        • Sheldon R.
        • Thorpe K.E.
        • et al.
        Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial.
        JAMA. 2003; 289: 2224-2229
        • Sud S.
        • Massel D.
        • Klein G.J.
        • et al.
        The expectation effect and cardiac pacing for refractory vasovagal syncope.
        Am J Med. 2007; 120: 54-62
      2. Transient loss of consciousness ('blackouts') management in adults and young people: NICE clinical guideline 109. https://www.nice.org.uk/guidance/cg109. In: (NICE) NIfHaCE, editor, August, 2010.

        • Romme J.J.C.M.
        • Reitsma J.B.
        • Black C.N.
        • et al.
        Drugs and pacemakers for vasovagal, carotid sinus and situational syncope (Review).
        The Cochrane Collaboration, Published in the Cochrane Library, 2013 (Available at: https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0016226/. Accessed March 1, 2017.)
        • Shen W.-K.
        • Sheldon R.S.
        • Benditt D.G.
        • et al.
        2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: a report of the American College of Cardiology Foundation, American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
        Heart Rhythm. 2017; 14: e218-e254
        • Jacobs A.K.
        • Kushner F.G.
        • Ettinger S.M.
        • et al.
        ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
        Circulation. 2013; 127: 268-310
        • Moher D.
        • Liberati A.
        • Tetzlaff J.
        • et al.
        Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
        J Clin Epidemiol. 2009; 62: 1006-1012
        • Higgins J.P.
        • Altman D.G.
        • Gotzsche P.C.
        • et al.
        The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
        BMJ. 2011; 343: d5928
      3. Wells GA, Shea B, O'Connell D, et al. Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm. Accessed March 1, 2017.

        • Viechtbauer W.
        Conducting Meta-Analyses in R with the metafor Package.
        J Stat Softw. 2010; 36: 1-48
        • Brignole M.
        • Menozzi C.
        • Gianfranchi L.
        • et al.
        A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope.
        Am J Cardiol. 1992; 70: 339-342